Abstract
As the abnormal expression of p53 protein is prognostically significant in some human cancers, its significance in patients with B-cell chronic lymphocytic leukaemia (CLL) was assessed. Two investigators evaluated the percentage of bone marrow mononuclear cells that stained for p53, using biopsies stained with anti-p53 monoclonal antibody (DO-7), and graded the degree of staining (0, +, ++, +++). Samples from a cohort of 90 patients with CLL were studied (median age 60 years, range 30-89 years; 57 patients were (63%) previously untreated, 22 patients (24%) had received one or two prior regimens, 11 patients had received (12%) three to seven regimens. The overall percentage of cells positive for p53 staining was a median of 43 (range 1-88). No investigator effect was detected either in overall percentage cells rated p53 positive or on the degree of staining (Pearson's correlation coefficient 0.980, P-value < 0.001). A Cox proportional hazards model showed that the percentage of ++ and +++ p53-positive cells correlated with various prognostic factors in CLL (P < 0.0001). A multivariate model incorporating prior therapy, Rai stage, beta2 microglobulin (beta2M) and p53 expression showed that only the percentage of p53-positive cell...Continue Reading
References
Jul 2, 1992·Nature·D P Lane
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G GaidanoR Dalla-Favera
Jan 1, 1995·Cancer Treatment and Research·P M Grambsch
Dec 1, 1994·British Journal of Haematology·D GandiniL del Senno
Aug 15, 1994·International Journal of Cancer. Journal International Du Cancer·M Aguilar-SantelisesM Jondal
Feb 7, 1997·Cell·A J Levine
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M O'BrienM Keating
May 12, 2001·Advances in Renal Replacement Therapy·R S Goldman
Feb 8, 2002·The New England Journal of Medicine·Ian F PollackUNKNOWN Children's Cancer Group
Mar 20, 2002·Nature Reviews. Cancer·A N Bullock, A R Fersht
Apr 19, 2002·Biochimica Et Biophysica Acta·Karen H Vousden
Jun 12, 2002·Current Treatment Options in Oncology·J H Ward
Aug 1, 2002·Blood·Ke LinAndrew R Pettitt
Citations
Mar 7, 2006·Annals of Hematology·Carl R WillisIan W Flinn
Sep 8, 2005·Blood·Jennifer S CarewPeng Huang
Oct 30, 2009·Leukemia & Lymphoma·Ellen J SchletteConstantine Tam
Mar 11, 2004·Mayo Clinic Proceedings·Tait D Shanafelt, Timothy G Call
Dec 22, 2009·American Journal of Clinical Pathology·Hong ChangConnie X Y Qi
Mar 18, 2008·Best Practice & Research. Clinical Haematology·Elihu H Estey
Nov 18, 2003·British Journal of Haematology·Julio Delgado, Maria Cristina Fernandez-Jimenez
Mar 8, 2007·British Journal of Haematology·Gautam BorthakurMichael J Keating
Nov 22, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Arjen H G ClevenRobert P Hasserjian
Mar 21, 2015·PloS One·Yin-Kai ChenHwei-Fang Tien
Feb 6, 2004·Hematological Oncology
Apr 2, 2011·Cancer·Issa F KhouriMarcelo Fernandez-Vina
Oct 25, 2003·Blood·Tait D ShanafeltNeil E Kay
Aug 1, 2020·The Cochrane Database of Systematic Reviews·Nina KreuzbergerNicole Skoetz
Mar 9, 2005·Cancer Research·Ronit RotemEliezer Flescher